These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21549838)

  • 21. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
    Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
    Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.
    Cadete A; Alonso MJ
    Nanomedicine (Lond); 2016 Sep; 11(17):2341-57. PubMed ID: 27526874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A toolbox for the upscaling of ethanolic human serum albumin (HSA) desolvation.
    Wacker M; Zensi A; Kufleitner J; Ruff A; Schütz J; Stockburger T; Marstaller T; Vogel V
    Int J Pharm; 2011 Jul; 414(1-2):225-32. PubMed ID: 21571055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part I. Synthesis, characterization and in vitro investigation.
    Negi LM; Talegaonkar S; Jaggi M; Verma AK; Verma R; Dobhal S; Kumar V
    Colloids Surf B Biointerfaces; 2014 Nov; 123():600-9. PubMed ID: 25454761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High and low molecular weight hyaluronic acid differentially regulate human fibrocyte differentiation.
    Maharjan AS; Pilling D; Gomer RH
    PLoS One; 2011; 6(10):e26078. PubMed ID: 22022512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fabrication of biocompatible and tumor-targeting hyaluronan nanospheres by a modified desolvation method.
    Zheng W; Li Y; Du J; Yin Z
    J Pharm Sci; 2014 May; 103(5):1529-37. PubMed ID: 24604299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Micro/nanostructured hyaluronic acid matrices with tuned swelling and drug release properties.
    Minaberry Y; Chiappetta DA; Sosnik A; Jobbágy M
    Biomacromolecules; 2013 Jan; 14(1):1-9. PubMed ID: 23157442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release.
    Souza LG; Silva EJ; Martins AL; Mota MF; Braga RC; Lima EM; Valadares MC; Taveira SF; Marreto RN
    Eur J Pharm Biopharm; 2011 Sep; 79(1):189-96. PubMed ID: 21352915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation, characterization and in vitro drug release studies of novel polymeric nanoparticles.
    Nimesh S; Manchanda R; Kumar R; Saxena A; Chaudhary P; Yadav V; Mozumdar S; Chandra R
    Int J Pharm; 2006 Oct; 323(1-2):146-52. PubMed ID: 16920286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the assembly process and properties of novel crosslinker-free hyaluronate-based polyelectrolyte complex nanocarriers.
    Umerska A; Paluch KJ; Inkielewicz-Stępniak I; Santos-Martinez MJ; Corrigan OI; Medina C; Tajber L
    Int J Pharm; 2012 Oct; 436(1-2):75-87. PubMed ID: 22814226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles.
    Bravo-Osuna I; Schmitz T; Bernkop-Schnürch A; Vauthier C; Ponchel G
    Int J Pharm; 2006 Jun; 316(1-2):170-5. PubMed ID: 16580797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling.
    Ali HS; York P; Ali AM; Blagden N
    J Control Release; 2011 Jan; 149(2):175-81. PubMed ID: 20946923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
    Abdel-Mottaleb MM; Neumann D; Lamprecht A
    Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational and experimental approaches for chitosan-based nano PECs design: Insights on a deeper comprehension of nanostructure formation.
    Boni FI; Cury BSF; Ferreira NN; Teixeira DA; Gremião MPD
    Carbohydr Polym; 2021 Feb; 254():117444. PubMed ID: 33357914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protamine-based nanoparticles as new antigen delivery systems.
    González-Aramundiz JV; Peleteiro Olmedo M; González-Fernández Á; Alonso Fernández MJ; Csaba NS
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):51-9. PubMed ID: 26455338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zinc incorporation capacity of whey protein nanoparticles prepared with desolvation with ethanol.
    Gülseren İ; Fang Y; Corredig M
    Food Chem; 2012 Nov; 135(2):770-4. PubMed ID: 22868157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.